Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst, Jean‐Charles Soria, Marcin Kowanetz et al. · Nature · 2014 · 5.2K citations

Medicine, Biomarker Target, Anti-pd-l1 Antibody Mpdl3280a +10

THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL

Robert Tibshirani · Statistics in Medicine · 1997 · 4.2K citations

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

Răzvan Cristescu, Robin Mogg, Mark Ayers et al. · Science · 2018 · 2.3K citations

Checkpoint Blockade Immunotherapy, Immunology, Immune Cell Therapy +16

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer

Laura Mezquita, Édouard Auclin, Roberto Ferrara et al. · JAMA Oncology · 2018 · 925 citations · Full text

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

Yuan Zhang, Lei Chen, Guoqing Hu et al. · New England Journal of Medicine · 2019 · 889 citations · Full text